Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Oncology
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Drug Development
Small Molecule Research & Development
Oncology
Fierce 50
Special Report
Awards Gala
Awards
Outsourcing Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Subscribe
Biotech
Cell & Gene Therapy
Clinical Data
Oncology
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Drug Development
Small Molecule Research & Development
Oncology
Fierce 50
Special Report
Awards Gala
Awards
Outsourcing Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Electra Therapeutics
Electra Therapeutics
Biotech
Electra charges up with $350M from upsized IPO
Electra is the latest biotech to overshoot its IPO expectations as the inflammation-focused company brought in $350 million from its Nasdaq listing.,
James Waldron
Sep 18, 2026 2:58am
Electra seeks $342M IPO to power inflammatory drug’s ph. 3 push
Sep 14, 2026 8:52am
Electra aims to light up Nasdaq with IPO for phase 2/3 I&I push
Aug 31, 2026 11:27am
Electra shines with $183M fundraise for rare disease trial
Oct 22, 2025 8:26am
Sanofi, Lilly, Amarin & more—Chutes & Ladders
Jun 7, 2024 8:30am
Jay Bradner returns to lead R&D at Amgen—Chutes & Ladders
Dec 15, 2023 9:30am
